临床肝胆病杂志2025，Vol.41Issue(10)：2141-2148,8.DOI:10.12449/JCH251027
肝纤维化治疗药物的研究进展
Research advances in therapeutic drugs for hepatic fibrosis
摘要
Abstract
Hepatic fibrosis is a chronic pathological condition characterized by hepatic stellate cell activation and excessive deposition of extracellular matrix,which would progress to liver cirrhosis and even hepatocellular carcinoma.Therefore,reversal of hepatic fibrosis is of great importance for improving quality of life and prolonging survival time.Currently,various therapeutic drugs for hepatic fibrosis have entered the stage of clinical trial.This article reviews the research advances in therapeutic drugs for hepatic fibrosis in the recent years,in order to provide insights into the treatment of hepatic fibrosis and future research directions for drugs.关键词
肝纤维化/药物疗法/治疗结果Key words
Hepatic Fibrosis/Drug Therapy/Treatment Outcome引用本文复制引用
黄健,宫雪晴,曾颜,李晖..肝纤维化治疗药物的研究进展[J].临床肝胆病杂志,2025,41(10):2141-2148,8.基金项目
国家自然科学基金面上项目(82274323) （82274323）
四川省科技厅重点研发项目(2024YFFK0150) （2024YFFK0150）
成都市卫生健康委员会成都中医药大学委校联合创新基金(WXLH202403100) General Project of National Natural Science Foundation of China(82274323) （WXLH202403100）
Key Research and Development Project of Sichuan Provincial Department of Science and Technology(2024YFFK0150) （2024YFFK0150）
Joint Innovation Fund of Health Commission of Chengdu and Chengdu University of Traditional Chinese Medicine(WXLH202403100) （WXLH202403100）
